Get it on Google Play

AbbVie (ABBV) Granted FDA Orphan Drug Designation for Treatment of Small Cell Lung Cancer

July 29, 2021 1:21 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

AbbVie (NYSE: ABBV) Granted FDA Orphan Drug Designation for Treatment of Small Cell Lung Cancer.

Generic Name: an antibody-drug conjugate of humanized, cysteine-engineered IgG1 monoclonal antibody targeting seizure-related 6 homolog conjugated to N-acetyl-gamma-calicheamicin



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

FDA

Related Entities

FDA